Drug Safety Newsletter 39th Edition
15 November 2010
Topics covered in this edition of the newsletter include:
- Gardasil - update on national monitoring experience
- Tamoxifen - risk of reduced therapeutic response
- Oral Bisphosphonates and risk of oesophageal adverse reactions
- Calcium Gloconate - risk of aluminium exposure with glass ampoules
- Adverse reaction reporting experience during 2009
Drug Safety Newsletter - 39th edition